Cycling in PD in Those Who Can’t Walk: Is it Possible?
You can find out more about NPF's National Medical Director, Dr. Michael S. Okun, by also visiting the NPF Center of Excellence, University of Florida Center for Movement Disorders & Neurorestoration.
This month a report appeared in the New England Journal of Medicine by Snijders and Bloem about a patient they encountered in their National Parkinson Foundation Center of Excellence Clinic. The report was accompanied by a dramatic video revealing a late stage Parkinson’s disease patient with severe ambulation difficulties and freezing of gait. The patient had Parkinson’s disease for many years, but his report of being able to ride a bicycle for six or more miles each day struck Dr. Bloem as “very interesting.”
One thing I have personally learned over many years of caring for persons with Parkinson’s disease is that when they tell you something, even if it sounds improbable, it is likely true. Bloem and colleagues did the right thing by following up this special case, and by documenting its occurrence by direct observation. Their report follows in the wake of another observation by Dr. Jay Alberts who demonstrated that tandem biking and forced exercise may be beneficial in Parkinson’s disease. Albert’s observation was made while tandem biking with a Parkinson’s disease patient in the back seat—all the way across the state of Iowa. As a trainee I witnessed a Parkinsonian woman who could not walk, but could dance for hours. How many more of these cases are out there? Can these observations be extended to help others? We hope the answer is yes.
The real question in this case is why does cycling improve symptoms? Why could Bloem’s patient ride a bicycle, but not walk? The answer remains a mystery, but many experts believe the answer may lie deep in the brain within a group of complex communicating structures (e.g. the basal ganglia). This network of structures aid in facilitating motor, mood and cognitive functions. How the basal ganglia works remains one of humankind’s greatest mysteries. We believe that these systems act as advanced data processors modulating complex brain functions by filtering and sorting information. Perhaps it was the basal ganglia itself that facilitated this man’s ability to ride the bike. Alternatively, the basal ganglia may have been bypassed by other brain systems in order to facilitate his complex riding movement. Basal ganglia diseases (e.g. Parkinson’s or other movement disorders) are known to be worsened by stress and anxiety (e.g. sleep deprivation or marital issues), but also are known to be improved by mood, exercise, visual/other cues, as well as many non-pharmacological/non-surgical modalities (e.g. Tai Chi). We need to learn more about how the basal ganglia work.
Dr. Bloem in a recent interview with the NY Times noted that he “was not advocating that Parkinson’s patients hop on bikes and go out on busy roads. They need help in mounting a bike and can get into trouble if they have to stop at traffic lights. They need to ride in safe areas.” He recommended that patients ride tricycles, or use stationary bikes or trainers — devices that turn road bikes into stationary ones. He also intimated that in select patients “bicycling offers an opportunity to be symptom-free, and to get some real cardiovascular exercise even when their disease is so far advanced that they cannot walk.” The Snijders/Bloem observation remains interesting, but we also want to caution all patients with PD not to run out and do it. Sudden offs, balance problems and many other complex issues could lead to crashes and severe injury. It is best to get the advice of a doctor and physical therapist, and if you choose to ride into the sunset on your bike, do it under careful supervision. Finally, in answer to the title of this article, “Is It Possible?” the answer is simple—almost anything is plausible and even possible in a Parkinson’s disease patient. This is the main reason why we as a Parkinson’s disease community are filled with hope and expectation about the future.
Read the full New York Times article here: "Cycling Provides a Break for Some with Parkinson's."
Snijders AH, Bloem BR. Cycling for freezing of gait. N Engl J Med. 2010 Apr 1;362(13):e46. PubMed PMID: 20357278.
Ridgel AL, Vitek JL, Alberts JL. Forced, not voluntary, exercise improves motor function in Parkinson's disease patients. Neurorehabil Neural Repair. 2009 Jul-Aug;23(6):600-8. Epub 2009 Jan 8. PubMed PMID: 19131578.
Posted: 4/7/2010 11:15:02 AM by
Browse current and archived What's Hot in PD? articles, the National Parkinson Foundation's monthly blog for people with Parkinson's written by our National Medical Director, Dr. Michael S. Okun.
Is Midlife Migraine Related to Late Life Parkinson’s Disease?
Deep Brain Stimulation for Parkinson’s Disease: NPF Congratulates Mahlon DeLong and Alim-Louis Benabid and Looks to a Bright Future in Human Neural-Network Modulation
Everything You Need to Know About Medical Marijuana and Parkinson’s Disease
The End for Levodopa Phobia: New Study Shows Sinemet is a Safe Initial Therapy for Treatment of Parkinson's Disease
Is light therapy a potential treatment modality in Parkinson’s disease?
How does the most common genetic cause of Parkinson’s Disease (LRRK2) cause Parkinson’s disease and could it be used to help develop a better therapy?
An Update on DAT Scanning for Parkinson’s Disease Diagnosis
Could Northera (Droxidopa) Be an Alternative Treatment for Low Blood Pressure and Passing Out Symptoms?
The Dream of a Pill Free Existence and the Continuous Dopaminergic Pump for the Treatment of Parkinson's Disease
Should I take Inosine to Raise my Uric Acid Levels and Treat my Parkinson’s Disease?
Could Fungus and Mold be an Important Contributor to Parkinson’s Disease?
Pimavanserin and the Hope for a Better Drug for Hallucinations and Psychosis in Parkinson’s Disease
Halting of the Creatine Study
The Importance of Identifying and Treating Caregiver Strain
Putting Parkinson’s Disease Information into the Palm of Your Hand: Parkinson’s Enters the Smartphon
What Parkinson’s Disease Patients Need to Know about H. Pylori Gastrointestinal Infections
A2A Receptor Antagonists and Parkinson’s Disease Treatment
Another Setback for Trophic Factor Treatment in Parkinson's Disease
IPX066 and What Patients Really Want in New Carbidopa/Levodopa (Sinemet) Formulations
The Weather Forecast for Parkinson’s Disease Calls for Worldwide Economic Storm
Defeating the Barriers to Implementing Exercise Regimens in Parkinson’s Disease Patients
When should you start medication therapy for Parkinson’s disease?
Neurologist Care Reduces Hospitalizations in Parkinson's Disease
A Victory in Court for Parkinson's Disease Patients who Require Ongoing Rehabilitative Therapies
Given the recent FDA announcement about Mirapex (pramipexole), should I be worried about dopamine agonists?
What about the new Parkinson’s Disease Vaccine? What should I know?
Caffeine as a Potential Treatment for Parkinson’s Disease
Time to Consider GPi DBS for Parkinson’s Disease: A Shift in the Practice of Patient Selection for DBS
A New Treatment for Parkinson’s Disease-Related Constipation
Too Many Pills: Improving Delivery Systems for Parkinson’s Disease Drugs
Measuring Quality and Assessing Depression in Parkinson's Disease
Watch out for Unexpected Obstacles if You Use a Cueing Strategy to Break Freezing of Gait in Parkinson’s Disease
Pill Color, Generic Medications and Insurance Issues: Important Medication-Related Tips for the Parkinson’s Disease Patient
Are Blood Tests for Parkinson’s Disease on the Horizon?
Placing Stem Cells in Animal Models of Parkinson’s Disease: Another Important Step
Important News for the Parkinson’s Disease Community: More Evidence that Sinemet and Madopar are Not Toxic and do Not Accelerate Disease Progression
The Case for All Parkinson’s Disease Patients to be Co-managed by a Primary Care-Neurologist Team
Scientists say Research on Brain Proteins Involved in Parkinson’s Disease is “Shaping” Up
Who Actually Takes Care of Most of the Parkinson’s Patients Worldwide: The Need for Education and the Parkinson’s Toolkit
If you are Dizzy or Passing Out, it could be Your Parkinson’s Disease or Parkinson’s Disease Medications
How Will Group Visits for Parkinson’s Disease Fit into the Future of Parkinson’s Disease Care?
Why Patients Should be Wary of Chelation Therapy for Parkinson’s Disease
Opening the Door to Gene Therapy in Parkinson’s Disease: The Need for Refinement of the Technology and Approach
Does it Matter if I Can’t Get Brand Sinemet?
Should I get a DaTscan or PET scan to confirm my diagnosis of Parkinson’s disease?
A Critical Reappraisal of the Worst Drugs in Parkinson’s Disease
Environmental Risks for PD: Manganese, Welding, Mining, and Parkinsonism
Calling for the FDA to Revise the Eight Sinemet a Day Rule
Dry Cleaning Solvents and Potential Environmental Risks for Developing Parkinson’s Disease
Maintaining the Balance: Why Parkinson’s Disease Patients Need to Understand Drug Recalls, Withdrawals, and Safety Alerts
Shining a Light on Parkinson’s Disease: Optogenetics Has a Bright Future in Research
Poor Medication Management of Parkinson's Disease During Hospital Admissions: Patients and Families Can Improve Their Hospital-Based Management
Why Are Patches and Continuous Release Technology a Big Deal to Parkinson's?
Is the PD SURG Trial Another Surge Forward for DBS Therapy?
Cycling in PD in Those Who Can’t Walk: Is it Possible?
New iPS Stem Cells for PD: What Does it Mean?
Time for Comprehensive Care Networks for PD
Is Parkinson's Disease a Prion Disease?
Parkinson's Disease Linked to Gaucher's Disease
Brain Cells Keep Time Stamps: Implications for Parkinson's Disease Therapies
Is it Safe to Have an MRI with a DBS in Place?
Take Care of Your Bones as They Are Affected in Parkinson's Disease (Even in Men)
Is it Time to Start Paying Attention to Pain Symptoms in Parkinson's Disease Patients?
Glutathione Fails to Demonstrate Significant Improvement in PD Symptoms
Keeping an Eye on Trials Important to the Parkinson's Disease Patient
Increased Risk of Melanoma in Parkinson's Disease
Finally a DBS Expert Consensus Statement Aimed at Their True Customers: The Patients
Pesticides and Environmental Exposure in Parkinson's disease: Should We Stay Away From the Stink Truck?
Is Exercise Effective Treatment and Protection Against PD?
Why are Transplant Trials Struggling to Succeed in the Treatment of PD?
Are Monoamine Oxidase Inhibitors Disease Modifying or Neuroprotective in PD?
Update on Gene Therapy for Parkinson's Disease